Cargando…
The lowest effective plasma concentration of atomoxetine in pediatric patients with attention deficit/hyperactivity disorder: A non-randomized prospective interventional study
BACKGROUND: Atomoxetine (ATX) is used as a first-line, non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD), although no studies have systematically examined the relationship between plasma concentration and clinical efficacy. We conducted this non-randomized prospective inter...
Autores principales: | Sugimoto, Atsunori, Suzuki, Yutaro, Orime, Naoki, Hayashi, Taketsugu, Yoshinaga, Kiyohiro, Egawa, Jun, Ono, Shin, Sugai, Takuro, Inoue, Yoshimasa, Someya, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270591/ https://www.ncbi.nlm.nih.gov/pubmed/34232195 http://dx.doi.org/10.1097/MD.0000000000026552 |
Ejemplares similares
-
Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients
por: Sugimoto, Atsunori, et al.
Publicado: (2021) -
Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder
por: Zain, Ekachaeryanti, et al.
Publicado: (2023) -
Maternal exposure to pesticides during pregnancy and risk for attention-deficit/hyperactivity disorder in offspring: A protocol for systematic review and meta-analysis
por: Zhu, Zhixian, et al.
Publicado: (2021) -
Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder
por: Yoshinaga, Kiyohiro, et al.
Publicado: (2023) -
Hyperactivity of the default-mode network in first-episode, drug-naive schizophrenia at rest revealed by family-based case–control and traditional case–control designs
por: Guo, Wenbin, et al.
Publicado: (2017)